Chairman Jiang Xiaomeng Elected Vice President of Provincial Chamber of Commerce
Release time:
2020-08-14
Chairman Jiang Xiaomeng Elected Vice President of Provincial Chamber of Commerce
News 7# July 14-15 , the 11th Congress of Zhejiang Federation of Industry and Commerce was held in Hangzhou. Jiang Xiaomeng, chairman of the group company, was elected vice president of Zhejiang Chamber of Commerce and representative of the 12th Congress of the all-China Federation of Industry and Commerce at this meeting.
Feng Zhili, member of the Standing Committee of the Provincial Party Committee and Minister of the United Front Work Department of the Provincial Party Committee, attended the opening meeting and delivered a speech. Feng Ming, deputy director of the Standing Committee of the Provincial People's Congress, Cheng Yuechong, deputy governor, and Sun Wenyou, vice chairman of the Provincial Political Consultative Conference, attended the opening meeting. Feng Zhili said in his speech that since the Tenth Congress of the Provincial Federation of Industry and Commerce, the Provincial Federation of Industry and Commerce has thoroughly studied and implemented the spirit of General Secretary Xi Jinping's series of important speeches and new ideas, new ideas and strategies for governing the country, and adhered to the theme of "two health" work. Give full play to the unique advantages and important roles of united front, economic, and non-folk, and made important contributions to the economic and social development of our province. The 14th Provincial Party Congress comprehensively described the development blueprint of our province in the next five years, and sounded the assembly call for re-creating new advantages in the private economy. It is hoped that the Provincial Federation of Industry and Commerce will always put ideological and political guidance in the first place and guide the majority of non-public economy People consciously accept the leadership of the party and unswervingly follow the path of socialism with Chinese characteristics; actively focus on the overall situation of the center and play a functional role; effectively strengthen self-building, consolidate the work foundation, unite and lead the vast number of non-public enterprises and people in the non-public economy, unswervingly follow the path guided by the "August 8 Strategy", make new contributions to the realization of the "two high-level" goals in our province, and welcome the party with outstanding results The 19th National Congress of the Communist Party of China was successfully held.
A total of 546 people from the whole province, Zhejiang businessmen from outside the province, Hong Kong and Macao businessmen, new social strata and experts attended the meeting. The deputies conscientiously studied and implemented the spirit of the 14th Provincial Party Congress, listened to and examined the work report of the 10th Executive Committee of the Zhejiang Federation of Industry and Commerce, elected the 11th Executive Committee of the Provincial Federation of Industry and Commerce, elected 35 deputies to the 12th National Congress of the all-China Federation of Industry and Commerce, and examined relevant resolutions. Jiang Xiaomeng, chairman of the group company, was elected vice president of Zhejiang Chamber of Commerce and representative of the 12th Congress of the all-China Federation of Industry and Commerce. (this newspaper reporter)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page